These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
579 related articles for article (PubMed ID: 19000665)
1. Chromogranin A and C-terminal endothelin-1 precursor fragment add independent prognostic information to amino-terminal proBNP in patients with acute destabilized heart failure. Dieplinger B; Gegenhuber A; Struck J; Poelz W; Langsteger W; Haltmayer M; Mueller T Clin Chim Acta; 2009 Feb; 400(1-2):91-6. PubMed ID: 19000665 [TBL] [Abstract][Full Text] [Related]
2. B-type natriuretic peptide and amino terminal proBNP predict one-year mortality in short of breath patients independently of the baseline diagnosis of acute destabilized heart failure. Gegenhuber A; Mueller T; Dieplinger B; Poelz W; Pacher R; Haltmayer M Clin Chim Acta; 2006 Aug; 370(1-2):174-9. PubMed ID: 16600203 [TBL] [Abstract][Full Text] [Related]
3. Lack of decrease in plasma N-terminal pro-brain natriuretic peptide identifies acute heart failure patients with very poor outcome. Kubler P; Jankowska EA; Majda J; Reczuch K; Banasiak W; Ponikowski P Int J Cardiol; 2008 Oct; 129(3):373-8. PubMed ID: 18054808 [TBL] [Abstract][Full Text] [Related]
4. Chromogranin-A and N-terminal pro-brain natriuretic peptide: an excellent pair of biomarkers for diagnostics in patients with neuroendocrine tumor. Korse CM; Taal BG; de Groot CA; Bakker RH; Bonfrer JM J Clin Oncol; 2009 Sep; 27(26):4293-9. PubMed ID: 19667278 [TBL] [Abstract][Full Text] [Related]
5. Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea. Bayes-Genis A; Lloyd-Jones DM; van Kimmenade RR; Lainchbury JG; Richards AM; Ordoñez-Llanos J; Santaló M; Pinto YM; Januzzi JL Arch Intern Med; 2007 Feb; 167(4):400-7. PubMed ID: 17325303 [TBL] [Abstract][Full Text] [Related]
6. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563 [TBL] [Abstract][Full Text] [Related]
7. Hyponatremia, natriuretic peptides, and outcomes in acutely decompensated heart failure: results from the International Collaborative of NT-proBNP Study. Mohammed AA; van Kimmenade RR; Richards M; Bayes-Genis A; Pinto Y; Moore SA; Januzzi JL Circ Heart Fail; 2010 May; 3(3):354-61. PubMed ID: 20332419 [TBL] [Abstract][Full Text] [Related]
8. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction. Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526 [TBL] [Abstract][Full Text] [Related]
9. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. Anwaruddin S; Lloyd-Jones DM; Baggish A; Chen A; Krauser D; Tung R; Chae C; Januzzi JL J Am Coll Cardiol; 2006 Jan; 47(1):91-7. PubMed ID: 16386670 [TBL] [Abstract][Full Text] [Related]
10. Amino-terminal pro-B-type natriuretic peptide testing and prognosis in patients with acute dyspnea, including those with acute heart failure. Baggish AL; van Kimmenade RR; Januzzi JL Am J Cardiol; 2008 Feb; 101(3A):49-55. PubMed ID: 18243859 [TBL] [Abstract][Full Text] [Related]
11. Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. Morello A; Lloyd-Jones DM; Chae CU; van Kimmenade RR; Chen AC; Baggish AL; O'Donoghue M; Lee-Lewandrowski E; Januzzi JL Am Heart J; 2007 Jan; 153(1):90-7. PubMed ID: 17174644 [TBL] [Abstract][Full Text] [Related]
12. The relationship between N-terminal pro-brain natriuretic peptide and risk for hospitalization and mortality is curvilinear in patients with chronic heart failure. Schou M; Gustafsson F; Corell P; Kistorp CN; Kjaer A; Hildebrandt PR Am Heart J; 2007 Jul; 154(1):123-9. PubMed ID: 17584564 [TBL] [Abstract][Full Text] [Related]
13. Usefulness and predictive value of circulating NT-proBNP levels to stratify patients for referral and priority treatment in a specialized outpatient heart failure center. Amir O; Paz H; Ammar R; Yaniv N; Schliamser JE; Lewis BS Isr Med Assoc J; 2008 Feb; 10(2):109-12. PubMed ID: 18432021 [TBL] [Abstract][Full Text] [Related]
14. Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department. Januzzi JL; Sakhuja R; O'donoghue M; Baggish AL; Anwaruddin S; Chae CU; Cameron R; Krauser DG; Tung R; Camargo CA; Lloyd-Jones DM Arch Intern Med; 2006 Feb; 166(3):315-20. PubMed ID: 16476871 [TBL] [Abstract][Full Text] [Related]
15. Amino-terminal pro-B-type natriuretic peptide testing for inpatient monitoring and treatment guidance of acute destabilized heart failure. Bettencourt P; Januzzi JL Am J Cardiol; 2008 Feb; 101(3A):67-71. PubMed ID: 18243862 [TBL] [Abstract][Full Text] [Related]